Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2901 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Lannett wins approvals for generic Adoxa tablets

Doxycycline is indicated for the treatment of bacterial infections, such as urinary tract infections, acne, gonorrhea, chlamydia, periodontitis and others. Arthur Bedrosian, president and CEO of Lannett, said:

Incyte prices public offer at $9 per share

The size of the offering was increased from the originally announced nine million shares. Incyte also granted the underwriters a 30-day option to purchase an additional 1.57 million